Drug Delivery

Apr 01, 2016
BioPharm International
Selecting a delivery method early on may be beneficial.
Mar 03, 2016
The researchers examine the top 20 cancer drugs dosed by body size in the US, and estimate that drug companies will earn $1.8 billion in 2016 in revenue from leftover cancer drugs.
Feb 29, 2016
A reformulated version of Rose Bengal, PV-10, may be used to treat melanoma when injected directly into tumors.
Feb 04, 2016
By BioPharm International Editors
ViaCyte enters Phase I/Phase II clinical trials for VC-01, a candidate treatment for the treatment of type 1 diabetes.
Dec 11, 2015
By BioPharm International Editors
Researchers from Oregon State University develop a new three-drug delivery system for cancer treatment.
Dec 09, 2015
By BioPharm International Editors
Assembly Biosciences reported a successful clinical study validating the use of the Gemicel technology platform for the oral delivery of biologic medications.
Dec 04, 2015
The company plans to reformulate injectable products to make them into inhaled and intranasal medications.
Nov 19, 2015
By BioPharm International Editors
Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.
Nov 19, 2015
By BioPharm International Editors
Baxter expands capacity for lyophilized cytotoxic oncology therapies at its fill/finish facility in Halle, Germany.
Nov 13, 2015
BioPharm International
By BioPharm International Editors
A new consortium involving Arecor, Fujifilm Diosynth Biotechnologies, and the UK's Center for Process Innovation will focus on formulation innovation as a way to improve downstream processing and reduce biopharmaceutical cost.
native1_300x100
lorem ipsum